This is the authors' abstract. We don't add key points for this paper.
Vancomycin resistant Enterococci (VRE) are multidrug resistant emerging pathogens that can cause various hospital and community acquired infections with increased mortality and morbidity. VRE is now becoming a global threat due to limited treatment options. So, this cross-sectional study was undertaken to detect VRE in a tertiary care hospital of Bangladesh by both phenotypic and genotypic method. A total of 87 Enterococcus spp. isolated from different clinical samples in the laboratory of Department of Microbiology and Immunology of Bangladesh Medical University (BMU) were studied from March 2019-February 2020. Enterococci of this study comprises E. faecalis (65), E. faecium (20) and E. raffinosus (2). According to this study, 67.8%, 60.9%, 56.3%, 47.1% and 43.7% of Enterococci were resistant to ciprofloxacin, gentamicin, nitrofurantoin, ampicillin and cotrimoxazole respectively. VRE was detected phenotypically by determination of minimal inhibitory concentration (MIC) of vancomycin by agar dilution method and genotypically by detection of vanA and vanB gene by conventional PCR. The prevalence of VRE was 3.4% (3 out of 87). The highest MIC value of vancomycin 256 μg/ml and 128 μg/ml was observed in two and one VRE isolates respectively. The vanA gene was detected in all VRE isolates. Two (66.67%) VRE were isolated from urine and 1 (33.33%) from blood sample. All VRE isolates were E. faecium and only susceptible to Linezolid and Fosfomycin. Detection of VRE in this study place warrants strict infection control and prevention policy to combat this difficulty to treat pathogen. It also provides important data regarding susceptibility of Enterococcus spp. and VRE.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Momotaz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: